Literature DB >> 26784524

Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking.

Maj-Linda B Selenica1, Patrick Reid2, Gabriela Pena2, Jennifer Alvarez2, Jerry B Hunt1, Kevin R Nash2, Dave Morgan2, Marcia N Gordon2, Daniel C Lee3.   

Abstract

Inflammation, including microglial activation in the CNS, is an important hallmark in many neurodegenerative diseases. Microglial stimuli not only impact the brain microenvironment by production and release of cytokines and chemokines, but also influence the activity of bone marrow derived cells and blood born macrophage populations. In many diseases including brain disorders and spinal cord injury, researchers have tried to harbor the neuroprotective and repair properties of these subpopulations. Hematopoietic bone marrow derived cells (BMDCs) are of great interest, especially during gene therapy because certain hematopoietic cell subpopulations traffic to the sites of injury and inflammation. The aim of this study was to develop a method of labeling endogenous bone marrow derived cells through intraosseous impregnation of recombinant adeno-associated virus (rAAV) or lentivirus. We utilized rAAV serotype 9 (rAAV-9) or lentivirus for gene delivery of green florescence protein (GFP) to the mouse bone marrow cells. Flow cytometry showed that both viruses were able to efficiently transduce mouse bone marrow cells in vivo. However, the rAAV9-GFP viral construct transduced BMDCs more efficiently than the lentivirus (11.2% vs. 6.8%), as indicated by cellular GFP expression. We also demonstrate that GFP labeled cells correspond to bone marrow cells of myeloid origin using CD11b as a marker. Additionally, we characterized the ability of bone marrow derived, GFP labeled cells to extravasate into the brain parenchyma upon acute and subchronic neuroinflammatory stimuli in the mouse CNS. Viral mediated over expression of chemokine (C-C motif) ligand 2 (CCL2) or intracranial injection of lipopolysaccharide (LPS) recruited GFP labeled BMDCs from the periphery into the brain parenchyma compared to vehicle treated mice. Altogether our findings demonstrate a useful method of labeling endogenous BMDCs via viral transduction and the ability to track subpopulations throughout the body following insult or injury. Alternatively, this method might find utility in delivering therapeutic genes for neuroinflammatory conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone marrow infection; GFP labeling; Infiltration; Inflammation; Monocyte; Recombinant adeno-associated virus serotype 9

Mesh:

Substances:

Year:  2016        PMID: 26784524      PMCID: PMC4852145          DOI: 10.1016/j.jim.2016.01.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

Review 1.  Do bone marrow cells generate neurons?

Authors:  David C Hess; William D Hill; James E Carroll; Cesar V Borlongan
Journal:  Arch Neurol       Date:  2004-04

2.  The growing clinical impact of gene therapy.

Authors:  Arthur Nienhuis
Journal:  Mol Ther       Date:  2008-06       Impact factor: 11.454

3.  Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

Authors:  Liujiang Song; M Ariel Kauss; Etana Kopin; Manasa Chandra; Taihra Ul-Hasan; Erin Miller; Giridhara R Jayandharan; Angela E Rivers; George V Aslanidi; Chen Ling; Baozheng Li; Wenqin Ma; Xiaomiao Li; Lourdes M Andino; Li Zhong; Alice F Tarantal; Mervin C Yoder; Kamehameha K Wong; Mengqun Tan; Saswati Chatterjee; Arun Srivastava
Journal:  Cytotherapy       Date:  2013-08       Impact factor: 5.414

4.  Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.

Authors:  Tarja M Malm; Milla Koistinaho; Maria Pärepalo; Tero Vatanen; Andreas Ooka; Stefan Karlsson; Jari Koistinaho
Journal:  Neurobiol Dis       Date:  2005-02       Impact factor: 5.996

5.  Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy.

Authors:  Jheel Pandya; Luis Ortiz; Chen Ling; Angela E Rivers; George Aslanidi
Journal:  Immunol Cell Biol       Date:  2013-11-12       Impact factor: 5.126

6.  Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

Authors:  Monica R P Elmore; Allison R Najafi; Maya A Koike; Nabil N Dagher; Elizabeth E Spangenberg; Rachel A Rice; Masashi Kitazawa; Bernice Matusow; Hoa Nguyen; Brian L West; Kim N Green
Journal:  Neuron       Date:  2014-04-16       Impact factor: 17.173

7.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

8.  Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation.

Authors:  Angela E Schellenberg; Richard Buist; Marc R Del Bigio; Henrik Toft-Hansen; Reza Khorooshi; Trevor Owens; James Peeling
Journal:  Fluids Barriers CNS       Date:  2012-04-30

9.  Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.

Authors:  Brian Spencer; Robert A Marr; Edward Rockenstein; Leslie Crews; Anthony Adame; Rewati Potkar; Christina Patrick; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  BMC Neurosci       Date:  2008-11-12       Impact factor: 3.288

10.  Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain.

Authors:  Maj-Linda B Selenica; Jennifer A Alvarez; Kevin R Nash; Daniel C Lee; Chuanhai Cao; Xiaoyang Lin; Patrick Reid; Peter R Mouton; Dave Morgan; Marcia N Gordon
Journal:  J Neuroinflammation       Date:  2013-07-17       Impact factor: 8.322

View more
  2 in total

1.  Transcriptional regulation of cyclophilin D by BMP/Smad signaling and its role in osteogenic differentiation.

Authors:  Rubens Sautchuk; Brianna H Kalicharan; Katherine Escalera-Rivera; Jennifer H Jonason; George A Porter; Hani A Awad; Roman A Eliseev
Journal:  Elife       Date:  2022-05-30       Impact factor: 8.713

2.  M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity.

Authors:  Hong-Yan Zhao; Yuan-Yuan Zhang; Tong Xing; Shu-Qian Tang; Qi Wen; Zhong-Shi Lyu; Meng Lv; Yu Wang; Lan-Ping Xu; Xiao-Hui Zhang; Yuan Kong; Xiao-Jun Huang
Journal:  Signal Transduct Target Ther       Date:  2021-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.